A randomized, double-blind, controlled comparative trial of the anti-aging
properties of non-prescription tri-retinol 1.1% vs. prescription tretinoin
0.025%.
Author(s): Ho ET, Trookman NS, Sperber BR, Rizer RL, Spindler R, Sonti S, Gotz V, Mehta R.
Affiliation(s): ScinMedica, Inc., Carlsbad, CA 92010, USA. eho@skinmedica.com
Publication date & source: 2012, J Drugs Dermatol. , 11(1):64-9
Vitamin A and its derivatives (commonly termed retinoids) are widely used in
topical anti-aging products. Certain retinoids such as retinol and its esters are
available without a prescription, while others such as tretinoin are available
only via prescription. A randomized, double-blind, controlled clinical study was
conducted to compare the efficacy and tolerability of a tri-retinol 1.1% gradual
release cream vs. tretinoin 0.025% cream in females with mild-to-moderate facial
photodamage. Subjects applied the test product to the entire face in the evening
after cleansing in a progressively increasing frequency starting twice weekly for
the first week, followed by three times weekly during the second week and then
daily as tolerated for the third week and beyond. Treatment was continued for a
total of three months. Clinical evaluations and standardized digital photographs
were performed at baseline and after four, eight, and 12 weeks of treatment.
Self-assessment questionnaires were completed by the subjects at four, eight, and
12 weeks to assess perceived efficacy of the test products. Thirty-four subjects
(16: tri-retinol and 18: tretinoin) completed the study. Both test products
significantly improved signs of photodamage, including fine and coarse periocular
wrinkles, skin firmness, skin tone, mottled pigmentation, tactile roughness,
overall photodamage and global photodamage improvement. There were no significant
differences in efficacy between the two products for these assessments. The
adverse effects (which were graded as mild or less) were those typically seen
with topical retinoids. Subjects reported >93 percent overall satisfaction with
both products at weeks 8 and 12.
|